Home / Health / Celldex Drug Excels in Skin Disease Trials
Celldex Drug Excels in Skin Disease Trials
22 Sep
Summary
- Celldex drug met main and secondary goals.
- Two late-stage clinical trials were completed.
- The drug targets a specific skin disease.
Celldex Therapeutics has reported significant success in its latest clinical trials for an experimental drug designed to treat a specific skin disease. The company announced on Tuesday that the investigational treatment met all primary and secondary endpoints in two separate late-stage studies.
These trial results are a crucial step forward, indicating potential efficacy and safety for the drug. The successful completion of late-stage trials suggests that the therapeutic may soon be available to patients suffering from this particular skin condition.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
